Abstract
ABSTRACTIn the radiosurgery era, the treatment strategies for vestibular schwannoma have changed at most centers. This new paradigm holds that rational CPA tumor therapy requires balancing often competing goals of therapy, and the associated risks and benefits of different therapies or combination of therapies. The present review discusses this new paradigm and its specific implications for CPA tumor surgery. Inevitably, such a review will focus largely on minimizing facial nerve morbidity, as this is both the most modifiable risk, and the risk that is most reduced with the use of adjuvant therapies, such as stereotactic radiosurgery (like Gamma knife). The facts about facial nerve preservation in CPA tumor surgery will be reviewed, and methods for avoiding facial nerve morbidity will be discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: An International Journal of Otorhinolaryngology Clinics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
